2Ballestshofer BM, Ritting K, Enderle MD,et al. Endothelial dysfunction is detectable in young normotensive first degree relatives of subjects with type 2 diabetes in association with insulin resistance [ J ]. Circulation, 2000,101 : 1780-1784.
3Choles HHR, Kasinath BS, Gorin Y, et al. Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy [ J ]. Kidney Int, 2002, 62: 8-17.
5Matsumoto K, Kanmatsuse K. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotie syndrome[J]. Clin Nephrol, 2001, 55: 269-274.
5[1] Espersen GT, Mathiesen O, Grunnet N, Jensen S et al. Cytokine plasma levels and lymphocyte subsets in patient withnewly diagnosed insulin-dependent (type 1)diabetes mellitus before and following initial insulin treatment[J]. APMIS, 1997; 101(6):703-706.
6[2] Thomas MP, Hemming P, Jens M et al. Monokine antagonism is reduced in patients with IDDM[J]. Diabetes, 1994； 43（10）:1242-1247.
7[3] Molvig， Bak L，Christensen P et al. Endotoxin-stimulated human monocyte secretion of interleukin-1, tumur necrosis factor alpha, and prostaglandin E2 shows stable interindividual difference[J]. Scand J Immunol, 1988; 27（6）:705-716.
8[4] Harrsion LC, Honeyman MC, De Aizpurua HJ et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subject at risk of insulin-dependent diabetes[J]. Lancet, 1993; 341（5）:1365-1369.
9[5] Foulis AK, McGill M,Farquharson MA. Insulitis in type 1 (insulin-γ dependent)diabetes mellitus in man: Macrophages,lymphocytes,and interferon-γ containing cells[J]. J Pathol, 1991;165（2）:97-103.
10[6] Kroemer G, Wick G. The role of interleukin-2 in autoimmunity [J]. Immunol Today, 1989; 10（2）:245-251.
